Mai H. Bui

1.9k total citations
21 papers, 741 citations indexed

About

Mai H. Bui is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mai H. Bui has authored 21 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Mai H. Bui's work include Cancer therapeutics and mechanisms (4 papers), Antioxidant Activity and Oxidative Stress (2 papers) and DNA Repair Mechanisms (2 papers). Mai H. Bui is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Antioxidant Activity and Oxidative Stress (2 papers) and DNA Repair Mechanisms (2 papers). Mai H. Bui collaborates with scholars based in United States, Switzerland and United Kingdom. Mai H. Bui's co-authors include Rita Wegmüller, Isabelle Herter‐Aeberli, Angela M. Nilius, Alain Sauty, Philippe Leuenberger, Robert K. Flamm, Laurel S. Almer, Jill Beyer, Zhi‐Fu Tao and John Xue and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Mai H. Bui

21 papers receiving 694 citations

Peers

Mai H. Bui
Nigel B. Rendell United Kingdom
Mary J. Wilson United States
Rui Vieira United Kingdom
Kelly Rose United States
Nigel B. Rendell United Kingdom
Mai H. Bui
Citations per year, relative to Mai H. Bui Mai H. Bui (= 1×) peers Nigel B. Rendell

Countries citing papers authored by Mai H. Bui

Since Specialization
Citations

This map shows the geographic impact of Mai H. Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai H. Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai H. Bui more than expected).

Fields of papers citing papers by Mai H. Bui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai H. Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai H. Bui. The network helps show where Mai H. Bui may publish in the future.

Co-authorship network of co-authors of Mai H. Bui

This figure shows the co-authorship network connecting the top 25 collaborators of Mai H. Bui. A scholar is included among the top collaborators of Mai H. Bui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai H. Bui. Mai H. Bui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bui, Mai H., et al.. (2024). Revisiting the determinants of cryptocurrency excess return: Does scarcity matter?. International Review of Economics & Finance. 96. 103733–103733. 2 indexed citations
2.
Bui, Mai H., et al.. (2019). The Relationship Of Dividend Policy and Share Price Volatility: A Case in Vietnam. Annals of economics and finance. 20(1). 123–136. 14 indexed citations
3.
Guo, Jun, Lloyd T. Lam, Kenton L. Longenecker, et al.. (2017). Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD+ biosynthesis pathway and NAMPT mutation. Biochemical and Biophysical Research Communications. 491(3). 681–686. 27 indexed citations
4.
Bui, Mai H., Xiaoyu Lin, Xiaoli Huang, et al.. (2016). Abstract 4738: The BET family bromodomain inhibitor ABBV-075 is a promising therapeutic agent for acute myeloid leukemia and myelodysplastic syndrome. Cancer Research. 76(14_Supplement). 4738–4738. 3 indexed citations
5.
Wegmüller, Rita, et al.. (2015). Micronutrient status and intake in omnivores, vegetarians and vegans in Switzerland. Zeitschrift für Ernährungswissenschaft. 56(1). 283–293. 217 indexed citations
6.
Herter‐Aeberli, Isabelle, et al.. (2013). Micronutrient status and intake in omnivores, vegetarians and vegans in Switzerland. Annals of Nutrition and Metabolism. 63. 1445–1445. 1 indexed citations
7.
Rohner, Fabian, Christine A. Northrop‐Clewes, Andres B. Tschannen, et al.. (2013). Prevalence and public health relevance of micronutrient deficiencies and undernutrition in pre-school children and women of reproductive age in Côte d'Ivoire, West Africa. Public Health Nutrition. 17(9). 2016–2028. 36 indexed citations
8.
Rohner, Fabian, et al.. (2011). Quantification of Vitamin A in Palm Oil Using a Fast and Simple Portable Device: Method Validation and Comparison to High-Performance Liquid Chromatography. International Journal for Vitamin and Nutrition Research. 81(5). 335–342. 21 indexed citations
9.
Yoon, Jeong‐Yeol, Jin‐Hee Han, Cheol Young Choi, Mai H. Bui, & Ryan Sinclair. (2009). Real-Time Detection of Escherichia coli in Water Pipe Using a Microfluidic Device with One-Step Latex Immunoagglutination Assay. Transactions of the ASABE. 52(3). 1031–1039. 2 indexed citations
10.
Xiao, Zhan, John Xue, Wen‐Zhen Gu, et al.. (2008). Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors. Biomarkers. 13(6). 579–596. 20 indexed citations
11.
Chen, Zehan, Zhan Xiao, Wen‐Zhen Gu, et al.. (2006). Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics. International Journal of Cancer. 119(12). 2784–2794. 103 indexed citations
12.
Hansen, Terkel, Peter J. Dandliker, Linda E. Chovan, et al.. (2005). Synthesis and antibacterial activity of 5-methoxy- and 5-hydroxy-6-fluoro-1,8-naphthyridone-3-carboxylic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 15(11). 2716–2719. 4 indexed citations
13.
Beebe, Xenia, Fan Yang, Mai H. Bui, et al.. (2004). Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides. Bioorganic & Medicinal Chemistry Letters. 14(10). 2417–2421. 16 indexed citations
14.
Beebe, Xenia, Angela M. Nilius, Philip J. Merta, et al.. (2003). Synthesis and SAR evaluation of oxadiazolopyrazines as selective Haemophilus influenzae antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 13(19). 3133–3136. 21 indexed citations
15.
Almer, Laurel S., Virginia D. Shortridge, Angela M. Nilius, et al.. (2002). Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 43(3). 225–232. 49 indexed citations
16.
Nilius, Angela M., Mai H. Bui, Laurel S. Almer, et al.. (2001). Comparative In Vitro Activity of ABT-773, a Novel Antibacterial Ketolide. Antimicrobial Agents and Chemotherapy. 45(7). 2163–2168. 30 indexed citations
17.
Elliott, Richard L., Daisy Pireh, George Griesgraber, et al.. (1998). Anhydrolide Macrolides. 1. Synthesis and Antibacterial Activity of 2,3-Anhydro-6-O-methyl 11,12-Carbamate Erythromycin A Analogues. Journal of Medicinal Chemistry. 41(10). 1651–1659. 31 indexed citations
18.
Bui, Mai H.. (1994). Simple determination of retinol, α-tocopherol and carotenoids (lutein, all-trans-lycopene, α- and β-carotenes) in human plasma by isocratic liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 654(1). 129–133. 74 indexed citations
19.
Bui, Mai H., et al.. (1992). Dietary Vitamin C Intake and Concentrations in the Body Fluids and Cells of Male Smokers and Nonsmokers. Journal of Nutrition. 122(2). 312–316. 60 indexed citations
20.
Bui, Mai H.. (1987). Sample Preparation and Liquid Chromatographic Determination of Vitamin Din Food Products. Journal of AOAC INTERNATIONAL. 70(5). 802–805. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026